Štorkánová H, Štorkánová L, Navrátilová A, Bečvář V, Hulejová H, Oreská S, Heřmánková B, Špiritović M, Bečvář R, Pavelka K, Vencovský J, Distler J, Šenolt L, Tomčík M (2023)
Publication Type: Journal article, Erratum
Publication year: 2023
Book Volume: 11
Article Number: 2736
Journal Issue: 10
DOI: 10.3390/biomedicines11102736
In the original publication [1], there was a mistake in Figure 4 as published. The representative picture of the immunohistochemistry staining for aSMA of the group entitled BLM (w1-6) + nintedanib (w4-6) was erroneously selected from a different group of mice. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
APA:
Štorkánová, H., Štorkánová, L., Navrátilová, A., Bečvář, V., Hulejová, H., Oreská, S.,... Tomčík, M. (2023). Correction to: Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin (Biomedicines, (2021), 9, 6, (650), 10.3390/biomedicines9060650). Biomedicines, 11(10). https://doi.org/10.3390/biomedicines11102736
MLA:
Štorkánová, Hana, et al. "Correction to: Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin (Biomedicines, (2021), 9, 6, (650), 10.3390/biomedicines9060650)." Biomedicines 11.10 (2023).
BibTeX: Download